brentuximab vedotin,trastuzumab deruxtecan
takeda,daiichi sankyo,seagen,astrazeneca
['adcetris', 'enhertu']
adcetris was a groundbreaking drug because it showed the potential of adcs as a new modality for targeted therapy. enhertu is the realization of that potential and has established adcs as a mainstay in oncology treatment
#esmo22
Biotech VC @YsiosCapital ?? | Molecular biologist | Alumnus @Vida_Ventures @harvardstemcell @embl | Wannabe historian ????